CDK6 and acute myeloid leukemia: A genome-scale CRISPR/Cas9 screen of 342 cancer cell lines revealed that AML cells are highly dependent on cyclin-dependent kinase 6 (CDK6) but not on its close homologue cyclin-dependent kinase 4 (CDK4) [2,3].